Sign in
8-K

Current Report

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-23-233693

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d387807d8k.htm…